<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Biol Res (Thessalon)</journal-id><journal-id journal-id-type="iso-abbrev">J Biol Res (Thessalon)</journal-id><journal-title-group><journal-title>Journal of Biological Research</journal-title></journal-title-group><issn pub-type="ppub">1790-045X</issn><issn pub-type="epub">2241-5793</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">115</article-id><article-id pub-id-type="doi">10.1186/s40709-020-00115-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>A review on Zika virus outbreak, epidemiology, transmission and infection dynamics</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kazmi</surname><given-names>Syeda Sidra</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Ali</surname><given-names>Waqar</given-names></name><address><email>waqarali@bs.qau.edu.pk</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bibi</surname><given-names>Nousheen</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Nouroz</surname><given-names>Faisal</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.440530.6</institution-id><institution>Department of Bioinformatics, </institution><institution>Hazara University Mansehra, </institution></institution-wrap>Mansehra, Pakistan </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.440530.6</institution-id><institution>Department of Botany, </institution><institution>Hazara University Mansehra, </institution></institution-wrap>Mansehra, Pakistan </aff></contrib-group><pub-date pub-type="epub"><day>4</day><month>3</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>4</day><month>3</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2020</year></pub-date><volume>27</volume><elocation-id>5</elocation-id><history><date date-type="received"><day>28</day><month>5</month><year>2019</year></date><date date-type="accepted"><day>24</day><month>2</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2020</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Zika virus (ZIKV) is a newly emergent relative of the Flaviviridae family and linked to dengue (DENV) and Chikungunya (CHIVKV). ZIKV is one of the rising pathogens promptly surpassing geographical borders. ZIKV infection was characterized by mild disease with fever, headache, rash, arthralgia and conjunctivitis, with exceptional reports of an association with Guillain&#x02013;Barre syndrome (GBS) and microcephaly. However, since the end of 2015, an increase in the number of GBS associated cases and an astonishing number of microcephaly in fetus and new-borns in&#x000a0;Brazil&#x000a0;have been related to ZIKV infection, raising serious worldwide public health concerns. ZIKV is transmitted by the bite of infected female mosquitoes of <italic>Aedes</italic> species. Clarifying such worrisome relationships is, thus, a current unavoidable goal. Here, we extensively described the current understanding of the effects of ZIKV on heath, clinical manifestation, diagnosis and treatment options based on modern, alternative and complementary medicines regarding the disease.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Zika virus</kwd><kwd><italic>Aedes</italic> mosquito</kwd><kwd>Epidemiology</kwd><kwd>Guillain&#x02013;Barr&#x000e9; syndrome</kwd><kwd>Microcephaly</kwd><kwd>Treatment</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">Among the family of viruses, Zika virus (ZIKV) is an emerging evolving virus on the western hemisphere, though it was initially reported from Uganda in 1940s [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Transmission of ZIKV is related to the two other imperative arbo-viruses including dengue virus (DENV) and chikungunya virus (CHIVKV) [<xref ref-type="bibr" rid="CR3">3</xref>]. In a quest to solve the dilemma of yellow fever, a study conducted in 1947 isolated the first novel virus from the blood of a sentinel rhesus macaque placed in the Zika Forest of Uganda [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. ZIKV stayed relatively silent for almost 70&#x000a0;years and all of a sudden emerged all over the America after Pacific Islands to Brazil [<xref ref-type="bibr" rid="CR6">6</xref>]. Recently it was identified that the ZIKV strain found in the Americas had escalated to Angola and was linked with a cluster of microcephaly [<xref ref-type="bibr" rid="CR7">7</xref>&#x02013;<xref ref-type="bibr" rid="CR9">9</xref>]. Hill et al. also reported similar results based on full virus genome analysis [<xref ref-type="bibr" rid="CR9">9</xref>]. All the above mentioned studies endorse overview of mosquito-borne transmission of the ZIKV strain from the Americas into continental Africa. World Health Organization (WHO) declared it as emergency of public health with international concern as a result of global alarm created by ZIKV by becoming first foremost infectious disease coupled with defects of human birth revealed in more than a half of century [<xref ref-type="bibr" rid="CR10">10</xref>].</p></sec><sec id="Sec2"><title>History and epidemiology of ZIKV</title><p id="Par3">ZIKV is a member of family Flaviviridae and spread through <italic>Aedes</italic> genus. Other members of this family include arboviruses, dengue virus and Japanese encephalitis viruses [<xref ref-type="bibr" rid="CR11">11</xref>]. ZIKV antibodies were also detected in animal species, especially non-human primates [<xref ref-type="bibr" rid="CR12">12</xref>]. ZIKV was also isolated from several mosquito species in Africa and Asia including arboreal mosquitoes as <italic>Aedes africanus</italic> or mosquitoes with a large tropical and subtropical distribution as <italic>Aedes aegypti</italic> [<xref ref-type="bibr" rid="CR13">13</xref>] and <italic>Aedes albopictus</italic>, respectively [<xref ref-type="bibr" rid="CR14">14</xref>]. Studies reported that ZIKV has three main lineages, two from Africa and one from Asia [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. The African lineage split in East and West African clusters [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. Asian lineage presents expanded geographical distribution [<xref ref-type="bibr" rid="CR18">18</xref>], since it emerged in the Pacific Ocean [<xref ref-type="bibr" rid="CR19">19</xref>] and South America [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. The 2015&#x02013;16 epidemic occurred in the America was due to strain of the Asian lineage generally known as the American strain [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. However, some consider the American outbreak strain as its own lineage. Epidemiology studies revealed distribution of ZIKV in half of the north African continent, Vietnam, Malaysia, Indonesia, Philippines, India, Thailand and Pakistan (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>) [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. The first human case was detected in Uganda in 1952 during a study indicating the presence of neutralizing antibodies to ZIKV in sera [<xref ref-type="bibr" rid="CR25">25</xref>]. Only few cases of infection in human were reported before 2007 when outbreak of ZIKV infection in humans occurred in Yap, Federated States of Micronesia, in the Pacific region [<xref ref-type="bibr" rid="CR26">26</xref>]. In French Polynesia the largest epidemic of ZIKV occurred during 2013 to 2014 and extended to New Caledonia, Cook Islands, Vanuatu, Easter Island, Solomon Islands and other Pacific Islands [<xref ref-type="bibr" rid="CR5">5</xref>]. ZIKV transmission is known in 55 countries and territories. However, only in 2015 to 2016, indigenous transmission have been reported for 41 of them, with indirect confirmation regarding circulation of virus in six countries, terminated outbreaks reported in five countries while three countries were affected with local infection [<xref ref-type="bibr" rid="CR27">27</xref>].<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Chronological time-line of ZIKV epidemic from 1947&#x02013;2016</p></caption><graphic xlink:href="40709_2020_115_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec3"><title>Molecular biology and virology</title><p id="Par4">Flaviviridae family contains clinically important arboviruses with four genera including <italic>Hepacivirus</italic> (one species that is hepatitis C virus), <italic>Pestivirus</italic> (four species), <italic>Pegivirus</italic> (two species) and <italic>Flavivirus</italic> (53 species). Other than hepatitis C virus, most of the clinically relevant pathogens belong to the genus <italic>Flavivirus</italic> [<xref ref-type="bibr" rid="CR28">28</xref>]. The most significant clinical manifestations by Flaviviruses include fever, rashes, encephalitis, visceral involvement and hemorrhagic fever [<xref ref-type="bibr" rid="CR29">29</xref>].</p><p id="Par5">The length of ZIKV genome is 10,794&#x000a0;kb, comprising a positive sense single-stranded RNA molecule having two noncoding regions (NCR); 39 and 59 NCR and a long open reading frame that encode a polyprotein: 59-C-prM-E-NS1-NS2A-NS2BNS3-NS4A-NS4B-NS5-39. The protein is cleaved into capsid (C), envelope (E), precursor of membrane (prM) and seven non-structural proteins (NS1-NS2A-NS2BNS3-NS4A-NS4B-NS5) (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>) [<xref ref-type="bibr" rid="CR30">30</xref>]. The major virion surface protein is E protein. This protein is involved in various features of the viral cycle, membrane fusion and mediating binding. The largest viral protein whose C-terminal portion has RNA-dependent RNA polymerase (RdRP) is NS5 protein activity and its N-terminus is responsible for RNA capping because of its processing due to methyl transferase activity [<xref ref-type="bibr" rid="CR31">31</xref>]. 428 nucleotides and 27 folding patterns are present in the 39 NCR of the ZIKV genome [<xref ref-type="bibr" rid="CR30">30</xref>]. These nucleotides and folding patterns may involve in the cyclization, translation, recognition by cellular factors, RNA packaging, recognition by viral factors and genome stabilization [<xref ref-type="bibr" rid="CR31">31</xref>].<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>The genome organization of ZIKV</p></caption><graphic xlink:href="40709_2020_115_Fig2_HTML" id="MO2"/></fig></p><p id="Par6">All identified structures of flaviviruses vary on the basis of amino acids that are framing a glycosylation spot in the shell of virus that is composed of two dissimilar proteins having 180 copies. ZIKV varies from other flaviviruses bulges by glycosylation spot on the surface of the virus. A carbohydrate molecule holds numerous sugars tied to the surface of viral protein at this spot. Surrounding residues and glycosylation site on ZIKV may be responsible for attachment of virus to human cells. The amino acids variations among different flaviviruses could suggest the differences in the varieties of human cells where it can attach and infect. If the function of glycosylation spot is analogous to DENV (attachment to the cells receptor of human body) it might be a worthy spot to be targeted by an antiviral compound [<xref ref-type="bibr" rid="CR32">32</xref>].</p><p id="Par7">Incubation period for ZIKV disease is around 2&#x02013;7&#x000a0;days [<xref ref-type="bibr" rid="CR33">33</xref>], with symptoms like influenza syndrome accompanying fever, malaise, headache, dizziness, stomachache, anorexia and maculopapular rash [<xref ref-type="bibr" rid="CR34">34</xref>]. It can also cause retro orbital eye pain, lymph adenopathy, diarrhea and oedema [<xref ref-type="bibr" rid="CR15">15</xref>]. Other indications reported are oedema of extremities, gastro intestinal disturbances, photophobia, cough malaise, back pain, aphthous ulcers and sweating. ZIKV infection can be misdiagnosed with other arboviruses and bacterial infections as not explicit to ZIKV infection, especially in prevalent areas. In French Polynesia serious neurological complications with Guillain&#x02013;Barr&#x000e9; syndrome was increased to 20-fold during the epidemic [<xref ref-type="bibr" rid="CR35">35</xref>].</p></sec><sec id="Sec4"><title>Transmission of ZIKV</title><sec id="Sec5"><title>ZIKV vector-borne transmission</title><p id="Par8"><italic>Aedes aegypti</italic>, <italic>Aedes polynesiensis</italic> and <italic>Aedes albopictus</italic> are the potential vectors responsible for the transmission of ZIKV infection by biting. <italic>Aedes aegypti</italic> is the foremost vector of DENV and CHIKV. <italic>Aedes polynesiensis</italic> is the main vector responsible for dissemination of lymphatic filariasis in French Polynesia. After the epidemic in French Polynesia these species of mosquitoes were collected and tested for ZIKV infection by RT-PCR and only one <italic>Aedes aegypti</italic> mosquito was confirmed having ZIKV RNA; experimental investigations showed the French Polynesian strain of <italic>Aedes aegypti</italic> can replicate the French Polynesian ZIKV strain (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1) [<xref ref-type="bibr" rid="CR36">36</xref>].</p><p id="Par9">Altogether, 61 countries and territories in six WHO regions have confirmation of conventional competent <italic>Aedes aegypti</italic> vectors but have not yet documented ZIKV transmission [<xref ref-type="bibr" rid="CR37">37</xref>]. Thus, risk of ZIKV spread to other countries is still likely. Might be due to lack of detection fewer countries did not report transmission. The re-emergence or re-introduction was also reported in all areas with prior reports of ZIKV transmission.</p><p id="Par10">Altogether in the African lineage eight mosquitoes were isolated, while P6-740 was the only mosquito isolated in the Asian lineage (Malaysia/1966). In 2007, ZIKV was identified in patients infected with <italic>Aedes aldopictus</italic>&#x000a0;mosquitoes from West Africa [<xref ref-type="bibr" rid="CR14">14</xref>]. However, the <italic>Aedes (stregomyia) hensilli</italic>&#x000a0;identified&#x000a0;as the probable principal vector that cause Micronesia outbreak [<xref ref-type="bibr" rid="CR38">38</xref>]. Later on, in 2013, the ZIKV spread out to French Polynesia, with consequent extent to Oceanian islands (New Caledonia, Cook islands, and Easter island), was mostly related with <italic>Aedes aegypti</italic>&#x000a0;and&#x000a0;<italic>Aedes aldopictus</italic>&#x000a0;species [<xref ref-type="bibr" rid="CR39">39</xref>]. The major symptoms such as rash, low-grade fever, arthralgia, conjunctivitis and GBS (Guillain&#x02013;Barr&#x000e9; syndrome) were observed in 11% of the total population [<xref ref-type="bibr" rid="CR40">40</xref>].&#x000a0;Furthermore, in Central-South America, <italic>Aedes aegypti</italic>&#x000a0;is considered as the utmost common vector for DENV [<xref ref-type="bibr" rid="CR41">41</xref>]. Later on in 2006, Chouin-Carneiro reported that the New World strains of <italic>Aedes aegypti</italic> and <italic>Aedes albopictus</italic> which found to be poor transmitters of ZIKV results in continuous divergence of the Asian lineage [<xref ref-type="bibr" rid="CR42">42</xref>]. These strains adopted alternative mode of transmission i.e. direct human to human transmission without the involvement of a vector. Indeed, while&#x000a0;<italic>Aedes</italic>&#x000a0;is widely accepted as the vector for ZIKV [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>], Guedes et al. has revealed that ZIKV can infect and replicate in the salivary glands, midgut, and was also spotted in saliva of&#x000a0;<italic>Culex</italic>&#x000a0;species [<xref ref-type="bibr" rid="CR45">45</xref>]. Altogether this work suggests that the transmission vector range for ZIKV may be larger than foreseen (although still a debatable topic demanding more exploration).</p></sec><sec id="Sec6"><title>Non-vector-borne transmission</title><p id="Par11">Non-vector-borne transmission of ZIKV infection can be caused during labor (mother to child), organ transplantation, blood transfusions and through sexual contact (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>).<fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Schematic diagram representing the transmission of ZIKV</p></caption><graphic xlink:href="40709_2020_115_Fig3_HTML" id="MO3"/></fig></p><p id="Par12">Antibodies against ZIKV were detected by Serosurvey studies in goats, rodents (<italic>Meriones hurrianae</italic> and <italic>Tatera indica</italic>), sheep and bats. These studies suggest that there is no clear association between ZIKV and a specific species of animal [<xref ref-type="bibr" rid="CR36">36</xref>]. In humans, it spreads through the bite of infected <italic>Aedes aegypti</italic> mosquitoes that are usually found in tropical and sub-tropical regions in domestic water-holding containers near dwellings [<xref ref-type="bibr" rid="CR33">33</xref>]. Consequently, when a mosquito bites a person already infected with ZIKV, the virus infected blood goes into the midgut and prevailed into the circulatory system. Another similar mosquito, <italic>Aedes albopictus</italic> can also transmit ZIKV. Among humans, transmission of this viral infection may also refer to sexual contact [<xref ref-type="bibr" rid="CR5">5</xref>]. High ZIKV RNA load has detected in breast milk, so transmission is possible by breast feeding and ZIKV can also be transmitted by blood transfusions [<xref ref-type="bibr" rid="CR46">46</xref>] as reported on December 2015 in Brazil, the first case of ZIKV blood transfusion transmission [<xref ref-type="bibr" rid="CR47">47</xref>]. ZIKV is adopted to transmit by enzootic and sub Urban cycle (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>); in enzootic setting this involves mosquitoes of <italic>Aedes</italic> species and non-human primates, however transmission in Urban setting involves human and mosquitoes of <italic>Aedes</italic> species demonstrate vector and non-vector borne transmission of ZIKV.<fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>Transmission cycle of ZIKV</p></caption><graphic xlink:href="40709_2020_115_Fig4_HTML" id="MO4"/></fig></p></sec><sec id="Sec7"><title>Pathophysiology and diagnosis</title><p id="Par13">In the beginning, ZIKV infection was misdiagnosed with dengue infection. Virus isolation and serological methods are carried out for laboratory diagnosis examination for ZIKV (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>) [<xref ref-type="bibr" rid="CR48">48</xref>]. Virus isolation needs several days (i.e. 1&#x02013;2&#x000a0;weeks) while convalescent and acute sampling and cross-reactions among flaviviruses are the limitations for serological methods [<xref ref-type="bibr" rid="CR15">15</xref>]. Cell culture may be utilized to isolate ZIKV [<xref ref-type="bibr" rid="CR5">5</xref>] but specialized laboratories are required to practice it [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. Reverse transcription PCR (RT-PCR) is used for confirmation of ZIKV infections whereas IgM against ZIKV can be detected by ELISA [<xref ref-type="bibr" rid="CR48">48</xref>]. RT-PCR is time saving, specific and sensitive in order to detect ZIKV in serum or cell culture [<xref ref-type="bibr" rid="CR15">15</xref>]. Molecular detection of ZIKV was increased when saliva was used at the acute phase of disease particularly in children and neonates as blood is difficult to collect [<xref ref-type="bibr" rid="CR5">5</xref>]. ZIKV fever diagnosis from PAHO is shown in Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>. RT-PCR for ZIKV is done on blood or saliva sample. Sequencing is performed if the results of RT-PCR are positive. ZIKV IgM serology comprises detection by immunofluorescence or ELISA, with confirmation by plaque reduction neutralization test (PRNT) if results are equivocal or positive [<xref ref-type="bibr" rid="CR36">36</xref>].<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Differential diagnosis of ZIKV infection includes various viral diseases with similar signs and symptoms as ZIKV infection [<xref ref-type="bibr" rid="CR49">49</xref>]</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">No</th><th align="left">Viral diseases</th><th align="left">Similarities with Zika virus</th><th align="left">Dissimilarities with Zika virus</th><th align="left">Diagnostic test</th></tr></thead><tbody><tr><td align="left">1</td><td align="left">Dengue fever</td><td align="left">High fever, severe muscle pain, and headache and may also be associated with hemorrhage</td><td align="left">Not associated with conjunctivitis</td><td align="left">Serology</td></tr><tr><td align="left">2</td><td align="left">Chikungunya</td><td align="left">High fever and intense joint pain affecting the hands, feet, knees, and back</td><td align="left">Not associated with conjunctivitis</td><td align="left">Serology</td></tr><tr><td align="left">3</td><td align="left">Parvovirus</td><td align="left">Acute and symmetric arthritis or arthralgia</td><td align="left">Rash may or may not be present</td><td align="left">Serology</td></tr><tr><td align="left">4</td><td align="left">Rubella</td><td align="left">Low-grade fever, Macular rash, arthritis, lymphadenopathy</td><td align="left">Not associated with conjunctivitis, coryza is not present in ZIKV infection</td><td align="left">Serology</td></tr><tr><td align="left">5</td><td align="left">Measles</td><td align="left">Fever, cough, conjunctivitis, and lymphadenitis. generalized rash</td><td align="left">Sore throat and coryza are not present in ZIKV infection</td><td align="left">Serology</td></tr><tr><td align="left">6</td><td align="left">Leptospirosis</td><td align="left">Fever, rigors, myalgia, conjunctival suffusion, headache, arthralgia&#x000a0;</td><td align="left">Distinguished from ZIKV infection by the presence of jaundice</td><td align="left">Serology</td></tr><tr><td align="left">7</td><td align="left">Malaria</td><td align="left">Fever, malaise, nausea, vomiting, abdominal pain, diarrhea, myalgia</td><td align="left">Dot associated with conjunctivitis</td><td align="left">Visualization of parasites on peripheral smear</td></tr><tr><td align="left">8</td><td align="left">Rickettsial infection</td><td align="left">African tick bite fever and relapsing fever. headache, fever, myalgia, regional lymphadenopathy, generalized rash&#x000a0;</td><td align="left">Not associated with conjunctivitis</td><td align="left">Direct smear and polymerase chain reaction</td></tr></tbody></table></table-wrap><fig id="Fig5"><label>Fig.&#x000a0;5</label><caption><p>Flow scheme for ZIKV fever diagnosis [<xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>]</p></caption><graphic xlink:href="40709_2020_115_Fig5_HTML" id="MO5"/></fig></p></sec></sec><sec id="Sec8"><title>Neurological complications of ZIKV infection</title><p id="Par14">Guillain&#x02013;Barr&#x000e9; syndrome and cases of other neurologic manifestations appears in Brazil and French Polynesia throughout ZIKV epidemics, even though it is self-limiting [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>]. A report from Ministry of Health of Brazil indicates that there is a possible relation between fetal deformities and infection with ZIKV in pregnancy, as the incidences of microcephaly cases among neonates have amplified by a factor of about 20 [<xref ref-type="bibr" rid="CR51">51</xref>]. ZIKV infection in fetus can be identified by Ultrasound in second or early third trimester [<xref ref-type="bibr" rid="CR52">52</xref>]. Approximately 5640 cases of central nervous system malformation and microcephaly have been stated by Brazil comprising 120 deaths in between 22nd October 2015 and 20th February 2016; however, only 163 cases of microcephaly were recorded in Brazil per year on average from 2001 to 2014. Of the 5640 cases, deaths of 120 children occurred during pregnancy or after birth and 30 of these were associated to congenital ZIKV infection [<xref ref-type="bibr" rid="CR53">53</xref>]. It has been published from the Para&#x000ed;ba State recently that ZIKV infection was detected in newborns having severe congenital CNS malformations. Among these, six cases were reported with confirmed laboratory results of ZIKV; in fetal tissues, amniotic fluid and placenta. All of these reported cases have history of visit to Brazil. There are increasing numbers of cases with intertwined relation between congenital CNS malformations during pregnancy and ZIKV infection [<xref ref-type="bibr" rid="CR54">54</xref>].</p></sec><sec id="Sec9"><title>Risk of Guillain&#x02013;Barr&#x000e9; syndrome</title><p id="Par15">Guillain&#x02013;Barr&#x000e9; syndrome (GBS) is one of the new complications and manifestations of ZIKV infection [<xref ref-type="bibr" rid="CR34">34</xref>]. GBS is a serious and life threatening neurological disorder eventually resulting in respiratory failure characterized by progressive muscular weakness [<xref ref-type="bibr" rid="CR55">55</xref>]. Outbreak of ZIKV in French Polynesia four&#x000a0;years ago added it to the viruses that can trigger GBS [<xref ref-type="bibr" rid="CR56">56</xref>]. WHO estimated there could be 3 to 4 million cases of this infection in the following year, therefore, there is a probability of hundreds of cases of GBS. Sufficient intravenous (IV) immunoglobulin (Ig) treatment for patients with ZIKV related GBS should be applied [<xref ref-type="bibr" rid="CR57">57</xref>]. Increased verification of a ZIKV infection based on laboratory results and GBS prevalence have been reported in 12 countries. In 2015, 1708 GBS cases were recorded in Brazil, indicating a 19% escalation from the preceding year as 1439 GBS cases were reported in 2014. 62% of GBS cases reported in Brazil had a history of signs and symptoms associated to this viral infection. 220 cases of GBS are reported in Colombia while 136 in El Salvador including 5 deaths in the time period from December 2015 to March 2016 [<xref ref-type="bibr" rid="CR53">53</xref>].</p></sec><sec id="Sec10"><title>Treatment of ZIKV</title><p id="Par16">In ZIKV infection, individuals should have adequate water intake, ample rest and treat pain and fever with liquid solutions. If the symptoms aggravate, they should look for counselling and therapeutic consideration (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>). There are no specific medications or vaccine available to treat or prevent ZIKV infections until now; only medications for symptomatic relief can be considered such as paracetamol to relieve pain and fever associated with this infection [<xref ref-type="bibr" rid="CR33">33</xref>]. Nonsteroidal anti-inflammatory drugs (NSAIDs) should be avoided and individuals should seek medical advice before taking additional medication if they are already taking medicines for another medical condition [<xref ref-type="bibr" rid="CR54">54</xref>]. Homeopathy is a worthy treatment option in ZIKV infection as it proved to be effective in Japanese encephalitis virus which is included in the same genus like Zika virus [<xref ref-type="bibr" rid="CR33">33</xref>]. Treatment with belladonna efficaciously reduced the severity of Japanese encephalitis virus infection [<xref ref-type="bibr" rid="CR58">58</xref>]. <italic>Atropa belladonna</italic> plant belongs to family Solanaceae [<xref ref-type="bibr" rid="CR59">59</xref>]. It has been effective in numerous medical conditions having great commercial significance as a major source of alkaloids, mainly scopolamine and hyoscyamine that are pharmaceutical bioactive compounds [<xref ref-type="bibr" rid="CR60">60</xref>]. Belladonna is native to North Africa, Western Asia and Europe. In <italic>Atropa belladonna</italic> majority of alkaloidal contents are present in ripe fruit and green leaves. It has been used from ancient times in order to treat various human ailments including menstrual disorders, headache, peptic ulcer, inflammation and histaminic reaction [<xref ref-type="bibr" rid="CR61">61</xref>]. Ultra-diluted belladonna concentrations like 1:10 or 1:100 are used in homeopathy and they are recommended for management of all the infectious diseases and illnesses [<xref ref-type="bibr" rid="CR62">62</xref>].<fig id="Fig6"><label>Fig.&#x000a0;6</label><caption><p>Schematic representation of possible ZIKV treatment</p></caption><graphic xlink:href="40709_2020_115_Fig6_HTML" id="MO6"/></fig></p><p id="Par17">Eupatorium is a naturally occurring pharmaceutical homeopathic compound effective against the symptoms of ZIKV disease, so it can be utilized as prophylactic treatment against ZIKV infection [<xref ref-type="bibr" rid="CR63">63</xref>]. <italic>Eupatorium perfoliatum</italic>, <italic>Rhustox</italic> and <italic>Atropa belladonna</italic> are the homeopathic prescriptions that may be utilized for ZIKV infection treatment. These medicinal agents are effective against the symptoms of ZIKV infection [<xref ref-type="bibr" rid="CR64">64</xref>]. During epidemics homeopathic pharmaceuticals are more effective in reduction of mortality and morbidity as compare to conventional system of medicines [<xref ref-type="bibr" rid="CR65">65</xref>].</p><p id="Par18">One of the utmost momentous features of ayurvedic structure is that they are natural substances and free from side effects and there is no scientific evidence of danger for human use [<xref ref-type="bibr" rid="CR66">66</xref>]. It is a primordial medical science that contains herbal medicines of natural origin with minimal side effects. <italic>Tinospora cordifolia</italic> is a herb and utilized for years as potential immunomodulator and effective natural remedy for viral disease of any nature. It boosts up the immune system and make body resistant enough to fight against infections. Theses herbs potentiate phagocytic abilities of macrophages [<xref ref-type="bibr" rid="CR67">67</xref>]. Intestinal sickness, urinary tract infections, dengue and swine influenza are effectively treated by the astringent characteristics of these ayurvedic plants so they might also be effective for ZIKV [<xref ref-type="bibr" rid="CR33">33</xref>].</p><p id="Par19">Beside homeopathic and ayurveda medicines, engineering approaches were also applied to develop peptide therapeutics and support the potential of a brain-penetrating peptide to treat neurotropic viral infections. Therapeutic treatment protected against mortality and evidently lessened symptoms, neuroinflammation and viral loads, furthermore mitigated microgliosis, neurodegeneration and brain damage [<xref ref-type="bibr" rid="CR68">68</xref>].</p><p id="Par20">Current medical recommendations are directed towards resolving symptoms and not the actual infection; however, ZIKV treatments and vaccines are in development. In 2016, WHO enlist all publicly affirmed commercial, government and academic-led projects focused at ZIKV interventions, together with vaccines [<xref ref-type="bibr" rid="CR69">69</xref>]. The list encompasses numerous approaches, comprising vaccines via purified inactivated virus, Virus-like particles (VLP), protein subunits, DNA and live recombinant attenuated viruses. Since April 2019, no vaccines have been permitted for clinical usage, though utmost were in the clinical stages of development [<xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR71">71</xref>].</p><p id="Par21">Suggested workflow for prompt discovery of drug counter to ZIKV is presented in Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>; whole process is proposed to initiate from screening moderate or high-throughput in vitro analysis development following with testing of approved drugs or other antiviral agents. Virtual screening based on docking could be selected for testing further compounds by means of advanced model of homology or phenotypic and genotypic analyses if drug repurposing will be unsuccessful. Priority can be given to the compounds resulting from docking for in vitro analysis in parallel. Consequent steps are typical as a pipeline in the discovery of any drug including developing the models of animals, clinical trial and if getting optimistic results, manufacturing the drug against ZIKV by scale up process, advertising and dissemination of drug [<xref ref-type="bibr" rid="CR72">72</xref>].<fig id="Fig7"><label>Fig.&#x000a0;7</label><caption><p>Proposed workflow for drug development against ZIKV</p></caption><graphic xlink:href="40709_2020_115_Fig7_HTML" id="MO7"/></fig></p></sec><sec id="Sec11"><title>Prevention and control of ZIKV</title><p id="Par22">Most precarious threats for ZIKV infection are mosquitoes including their reproducing localities. Their encounter with humans must be reduced in order to control and prevent their outspread. This can be employed by using mosquito repellents, mosquito nettings and closing the entrances and openings. Insect killing sprays recommended by the WHO Pesticide Evaluation Scheme should be used as larvicides [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. Insect repellents should not be used for babies under two months, mosquito nets should be used to protect babies from insect bite. Centre of disease control recommends mosquito repellents with active ingredients picaridin, DEET, eucalyptus oil, IR3535, oil of lemon and para-menthane-diol. These are safe for pregnant and lactating mothers [<xref ref-type="bibr" rid="CR54">54</xref>]. Repellants containing eucalyptus oil, lemon oil and para-menthane-diol should be avoided for children below 3&#x000a0;years of age. Mosquitoes should be killed using indoor mosquito killing sprays which contain active ingredient Imidacloprid and &#x003b2;-Cyfluthrin available in market [<xref ref-type="bibr" rid="CR75">75</xref>]. Flying insect fogger can also be used against the mosquitoes containing active ingredients Tetramethrin and Cypermethrin [<xref ref-type="bibr" rid="CR75">75</xref>]. Tests against ZIKV infection should be performed before blood transfusions to prevent transfusion related transmission. Pregnancy must be avoided in the high risk ZIKV infection prone areas before complete eradication or extra care must be exercised as microcephaly is associated with ZIKV infection [<xref ref-type="bibr" rid="CR76">76</xref>].</p><p id="Par23">Besides, different vector control strategies for averting Zika virus spread can be employed. Subjugation of mosquito population can be accomplished by a bacterium that can infect mosquitoes. Other strategies include the use of intracellular bacteria <italic>Wolbachia</italic>, which acts as a biopesticide to control mosquito population. Larvae of <italic>Toxorhynchites splendens</italic> mosquito species does not feed on blood. They feed on the larvae of other mosquito species, while the adults feed on honeydew, fruit, and nectar [<xref ref-type="bibr" rid="CR77">77</xref>]. Hence, the spread of ZIKV can be encountered by utilizing these species. <italic>Aedes</italic> species mosquitoes populations can also be suppressed by the strategy of using sterile males to induce sterility in wild fertile females [<xref ref-type="bibr" rid="CR78">78</xref>].</p></sec><sec id="Sec12"><title>Future directions</title><p id="Par24">Mosquito-borne epidemics are critically aggravating the pre-existing burden that the primary healthcare systems face. Work force will be affected and the societies may be threatened by the epidemic wave if they are not prepared well. Improved investigation and actions against response are required to alleviate the substantial burden on health systems and control promoting it worldwide. At present there is no vaccine available for ZIKV infection. Vaccines against flaviviral infections available for use of human are yellow fever vaccine, Japanese encephalitis vaccine, tick-borne encephalitis vaccines and dengue vaccine, so the rules for the vector borne infections must be followed in order to prevent ZIKV infection, as well as avoiding mosquito bite and control of vector is the only available options. Animal models of the ZIKV disease are immediately required not only for exhibiting the materno-fetal transmission and confirmation of its neurologic manifestations but also to report the influence of virus on host&#x02019;s immunity and reproductive health throughout the life. ZIKV infection is increasing dramatically, so it is the need of hour to take some necessary steps to eliminate this lethal infection and to constrain its future entrance as well. ZIKV specific rapid molecular diagnosis should be done urgently in order to detect the infection in less time before it aggravates. Modern techniques of molecular biology should be utilized to make vaccine specific to ZIKV. Research gaps should be addressed promptly and systematically. This can be accomplished by understanding the occurrence of broad spectrum clinical consequences that are resulting from fetal ZIKV infection and the environmental influences that effect their emergence. This also require the advancement of flaviviruses selective investigative tools, models of animals to detect developing effects of fetus resulting from viral septicity [<xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR80">80</xref>], novel products to control vector and strategies, effective medications and the vaccines to shield humans counter to ZIKV disease.</p></sec><sec sec-type="supplementary-material"><title>Supplementary information</title><sec id="Sec13"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="40709_2020_115_MOESM1_ESM.tif"><caption><p><bold>Additional file 1: Figure S1:</bold> Reproductive cycle of ZIKV.</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><sec><title>Supplementary information</title><p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s40709-020-00115-4.</p></sec><ack><title>Acknowledgements</title><p>Not applicable.</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>SSK: write the initial draft. WA: editing and proof reading. NB and FN: proof reading. All authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>Not applicable.</p></notes><notes><title>Ethics approval and consent to participate</title><p id="Par25">Not applicable.</p></notes><notes><title>Consent for publication</title><p id="Par26">Not applicable.</p></notes><notes notes-type="COI-statement"><title>Competing interests</title><p id="Par27">Authors declare no conflict of interest.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dick</surname><given-names>GWA</given-names></name><name><surname>Kitchen</surname><given-names>SF</given-names></name><name><surname>Haddow</surname><given-names>AJ</given-names></name></person-group><article-title>Zika virus (I). Isolations and serological specificity</article-title><source>Trans R Soc Trop Med Hyg</source><year>1952</year><volume>46</volume><fpage>509</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1016/0035-9203(52)90042-4</pub-id><?supplied-pmid 12995440?><pub-id pub-id-type="pmid">12995440</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leparc-Goffart</surname><given-names>I</given-names></name><name><surname>Nougairede</surname><given-names>A</given-names></name><name><surname>Cassadou</surname><given-names>S</given-names></name><name><surname>Prat</surname><given-names>C</given-names></name><name><surname>De Lamballerie</surname><given-names>X</given-names></name></person-group><article-title>Chikungunya in the Americas</article-title><source>Lancet.</source><year>2014</year><volume>383</volume><fpage>514</fpage><pub-id pub-id-type="doi">10.1016/S0140-6736(14)60185-9</pub-id><?supplied-pmid 24506907?><pub-id pub-id-type="pmid">24506907</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christofferson</surname><given-names>RC</given-names></name></person-group><article-title>Zika virus emergence and expansion: lessons learned from dengue and chikungunya may not provide all the answers</article-title><source>Am J Trop Med Hyg</source><year>2016</year><pub-id pub-id-type="doi">10.4269/ajtmh.15-0866</pub-id><?supplied-pmid 26903610?><pub-id pub-id-type="pmid">26903610</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>LR</given-names></name><name><surname>Jamieson</surname><given-names>DJ</given-names></name><name><surname>Powers</surname><given-names>AM</given-names></name><name><surname>Honein</surname><given-names>MA</given-names></name></person-group><article-title>Zika virus</article-title><source>N Eng J Med</source><year>2016</year><volume>374</volume><fpage>1552</fpage><lpage>1563</lpage><pub-id pub-id-type="doi">10.1056/NEJMra1602113</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musso</surname><given-names>D</given-names></name><name><surname>Roche</surname><given-names>C</given-names></name><name><surname>Robin</surname><given-names>E</given-names></name><name><surname>Nhan</surname><given-names>T</given-names></name><name><surname>Teissier</surname><given-names>A</given-names></name><name><surname>Cao-Lormeau</surname><given-names>V-M</given-names></name></person-group><article-title>Potential sexual transmission of Zika virus</article-title><source>Emerg Infect Dis</source><year>2015</year><volume>21</volume><fpage>359</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.3201/eid2102.141363</pub-id><?supplied-pmid 25625872?><pub-id pub-id-type="pmid">25625872</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fauci</surname><given-names>AS</given-names></name><name><surname>Morens</surname><given-names>DM</given-names></name></person-group><article-title>Zika virus in the Americas&#x02014;yet another arbovirus threat</article-title><source>N Engl J Med</source><year>2016</year><volume>374</volume><fpage>601</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1056/NEJMp1600297</pub-id><?supplied-pmid 26761185?><pub-id pub-id-type="pmid">26761185</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="other">World Health Organization Regional Office for Africa. Microcephaly&#x02014;suspected congenital Zika syndrome, Angola. Weekly bulletin on outbreaks and other emergencies; Week 48: 25 November-1 December 2017. Accessible at: <ext-link ext-link-type="uri" xlink:href="https://apps.who.int/iris/bitstream/handle/10665/259557/OEW48">https://apps.who.int/iris/bitstream/handle/10665/259557/OEW48</ext-link>- 2504122017.pdf?sequence&#x02009;=&#x02009;1.</mixed-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sassetti</surname><given-names>M</given-names></name><name><surname>Z&#x000e9;-Z&#x000e9;</surname><given-names>L</given-names></name><name><surname>Franco</surname><given-names>J</given-names></name><name><surname>Cunha</surname><given-names>JD</given-names></name><name><surname>Gomes</surname><given-names>A</given-names></name><name><surname>Tom&#x000e9;</surname><given-names>A</given-names></name><etal/></person-group><article-title>First case of confirmed congenital Zika syndrome in continental Africa</article-title><source>Trans R Soc Trop Med Hyg</source><year>2018</year><volume>112</volume><fpage>458</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1093/trstmh/try074</pub-id><?supplied-pmid 30053235?><pub-id pub-id-type="pmid">30053235</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>SC</given-names></name><name><surname>Vasconcelos</surname><given-names>J</given-names></name><name><surname>Neto</surname><given-names>Z</given-names></name><name><surname>Jandondo</surname><given-names>D</given-names></name><name><surname>Z&#x000e9;-Ze</surname><given-names>L</given-names></name><name><surname>Aguiar</surname><given-names>RS</given-names></name><etal/></person-group><article-title>Emergence of the Zika virus Asian lineage in Angola: an outbreak investigation</article-title><source>Lancet Inf Dis.</source><year>2019</year><pub-id pub-id-type="doi">10.1016/S1473-3099(19)30293-2</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roos</surname><given-names>RP</given-names></name></person-group><article-title>Zika virus&#x02014;a public health emergency of international concern</article-title><source>JAMA &#x0039d;eurol.</source><year>2016</year><volume>73</volume><fpage>1395</fpage><lpage>1396</lpage></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamel</surname><given-names>R</given-names></name><name><surname>Dejarnac</surname><given-names>O</given-names></name><name><surname>Wichit</surname><given-names>S</given-names></name><name><surname>Ekchariyawat</surname><given-names>P</given-names></name><name><surname>Neyret</surname><given-names>A</given-names></name><name><surname>Luplertlop</surname><given-names>N</given-names></name><etal/></person-group><article-title>Biology of Zika virus infection in human skin cells</article-title><source>J Virol</source><year>2015</year><volume>89</volume><fpage>8880</fpage><lpage>8896</lpage><pub-id pub-id-type="doi">10.1128/JVI.00354-15</pub-id><?supplied-pmid 4524089?><pub-id pub-id-type="pmid">26085147</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirya</surname><given-names>BG</given-names></name><name><surname>Okia</surname><given-names>NO</given-names></name></person-group><article-title>A yellow fever epizootic in Zika Forest, Uganda, during 1972: part 2: Monkey serology</article-title><source>Trans R Soc Trop Med Hyg</source><year>1977</year><volume>71</volume><fpage>300</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1016/0035-9203(77)90104-3</pub-id><?supplied-pmid 413216?><pub-id pub-id-type="pmid">413216</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchette</surname><given-names>NJ</given-names></name><name><surname>Garcia</surname><given-names>R</given-names></name><name><surname>Rudnick</surname><given-names>A</given-names></name></person-group><article-title>Isolation of Zika virus from <italic>Aedes aegypti</italic> mosquitoes in Malaysia</article-title><source>Am J Trop Med Hyg</source><year>1969</year><volume>18</volume><fpage>411</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1969.18.411</pub-id><?supplied-pmid 4976739?><pub-id pub-id-type="pmid">4976739</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grard</surname><given-names>G</given-names></name><name><surname>Caron</surname><given-names>M</given-names></name><name><surname>Mombo</surname><given-names>IM</given-names></name><name><surname>Nkoghe</surname><given-names>D</given-names></name><name><surname>Ondo</surname><given-names>SM</given-names></name><name><surname>Jiolle</surname><given-names>D</given-names></name><etal/></person-group><article-title>Zika virus in Gabon (Central Africa)&#x02014;2007: a new threat from <italic>Aedes albopictus</italic>?</article-title><source>PLoS Negl Trop Dis.</source><year>2014</year><volume>8</volume><fpage>e2681</fpage><pub-id pub-id-type="doi">10.1371/journal.pntd.0002681</pub-id><?supplied-pmid 24516683?><pub-id pub-id-type="pmid">24516683</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faye</surname><given-names>O</given-names></name><name><surname>Faye</surname><given-names>O</given-names></name><name><surname>Diallo</surname><given-names>D</given-names></name><name><surname>Diallo</surname><given-names>M</given-names></name><name><surname>Weidmann</surname><given-names>M</given-names></name><name><surname>Sall</surname><given-names>AA</given-names></name></person-group><article-title>Quantitative real-time PCR detection of Zika virus and evaluation with field-caught mosquitoes</article-title><source>Virol J.</source><year>2013</year><volume>2013</volume><issue>10</issue><fpage>311</fpage><pub-id pub-id-type="doi">10.1186/1743-422X-10-311</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanciotti</surname><given-names>RS</given-names></name><name><surname>Kosoy</surname><given-names>OL</given-names></name><name><surname>Laven</surname><given-names>JJ</given-names></name><name><surname>Velez</surname><given-names>JO</given-names></name><name><surname>Lambert</surname><given-names>AJ</given-names></name><name><surname>Johnson</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007</article-title><source>Emerg Infect Dis</source><year>2008</year><volume>14</volume><fpage>1232</fpage><lpage>1239</lpage><pub-id pub-id-type="doi">10.3201/eid1408.080287</pub-id><?supplied-pmid 18680646?><pub-id pub-id-type="pmid">18680646</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faye</surname><given-names>O</given-names></name><name><surname>Freire</surname><given-names>CCM</given-names></name><name><surname>Iamarino</surname><given-names>A</given-names></name><name><surname>Faye</surname><given-names>O</given-names></name><name><surname>de Oliveira</surname><given-names>JVC</given-names></name><name><surname>Diallo</surname><given-names>M</given-names></name><etal/></person-group><article-title>Molecular evolution of Zika virus during its emergence in the 20th century</article-title><source>PLoS Negl Trop Dis.</source><year>2014</year><volume>8</volume><fpage>e2636</fpage><pub-id pub-id-type="doi">10.1371/journal.pntd.0002636</pub-id><?supplied-pmid 24421913?><pub-id pub-id-type="pmid">24421913</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haddow</surname><given-names>AD</given-names></name><name><surname>Schuh</surname><given-names>AJ</given-names></name><name><surname>Yasuda</surname><given-names>CY</given-names></name><name><surname>Kasper</surname><given-names>MR</given-names></name><name><surname>Heang</surname><given-names>V</given-names></name><name><surname>Huy</surname><given-names>R</given-names></name><etal/></person-group><article-title>Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage</article-title><source>PLoS Negl Trop Dis.</source><year>2012</year><volume>6</volume><fpage>e1477</fpage><pub-id pub-id-type="doi">10.1371/journal.pntd.0001477</pub-id><?supplied-pmid 22389730?><pub-id pub-id-type="pmid">22389730</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao-Lormeau</surname><given-names>VM</given-names></name><name><surname>Roche</surname><given-names>C</given-names></name><name><surname>Teissier</surname><given-names>A</given-names></name><name><surname>Robin</surname><given-names>E</given-names></name><name><surname>Berry</surname><given-names>AL</given-names></name><name><surname>Mallet</surname><given-names>HP</given-names></name><etal/></person-group><article-title>Zika virus, French polynesia, South pacific, 2013</article-title><source>Emerg Infect Dis</source><year>2014</year><volume>20</volume><fpage>1085</fpage><lpage>1086</lpage><pub-id pub-id-type="doi">10.3201/eid2006.140138</pub-id><?supplied-pmid 24856001?><pub-id pub-id-type="pmid">24856001</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campos</surname><given-names>GS</given-names></name><name><surname>Bandeira</surname><given-names>AC</given-names></name><name><surname>Sardi</surname><given-names>SI</given-names></name></person-group><article-title>Zika virus outbreak, Bahia</article-title><source>Brazil. Emerg Infect Dis.</source><year>2015</year><volume>21</volume><fpage>1885</fpage><lpage>1886</lpage><pub-id pub-id-type="doi">10.3201/eid2110.150847</pub-id><?supplied-pmid 26401719?><pub-id pub-id-type="pmid">26401719</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zanluca</surname><given-names>C</given-names></name><name><surname>Melo</surname><given-names>VC</given-names></name><name><surname>Mosimann</surname><given-names>AL</given-names></name><name><surname>Santos</surname><given-names>GI</given-names></name><name><surname>Santos</surname><given-names>CN</given-names></name><name><surname>Luz</surname><given-names>K</given-names></name></person-group><article-title>First report of autochthonous transmission of Zika virus in Brazil</article-title><source>Mem Inst Oswaldo Cruz</source><year>2015</year><volume>110</volume><fpage>569</fpage><lpage>572</lpage><pub-id pub-id-type="doi">10.1590/0074-02760150192</pub-id><?supplied-pmid 26061233?><pub-id pub-id-type="pmid">26061233</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wongsurawat</surname><given-names>T</given-names></name><name><surname>Athipanyasilp</surname><given-names>N</given-names></name><name><surname>Jenjaroenpun</surname><given-names>P</given-names></name><name><surname>Jun</surname><given-names>SR</given-names></name><name><surname>Kaewnapan</surname><given-names>B</given-names></name><name><surname>Wassenaar</surname><given-names>TM</given-names></name><etal/></person-group><article-title>Case of microcephaly after congenital infection with Asian lineage Zika virus</article-title><source>Thailand. Emerg Infect Dis.</source><year>2018</year><pub-id pub-id-type="doi">10.3201/eid2409.180416</pub-id><?supplied-pmid 29985788?><pub-id pub-id-type="pmid">29985788</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lan</surname><given-names>PT</given-names></name><name><surname>Quang</surname><given-names>LC</given-names></name><name><surname>Huong</surname><given-names>VTQ</given-names></name><name><surname>Thuong</surname><given-names>NV</given-names></name><name><surname>Hung</surname><given-names>PC</given-names></name><name><surname>Huong</surname><given-names>TTLN</given-names></name><etal/></person-group><article-title>Fetal Zika virus infection in Vietnam</article-title><source>PLOS Curr.</source><year>2017</year><pub-id pub-id-type="doi">10.1371/currents.outbreaks.1c8f631e0ef8cd7777d639eba48647fa</pub-id><?supplied-pmid 29188136?><pub-id pub-id-type="pmid">29188136</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olson</surname><given-names>JG</given-names></name><name><surname>Ksiazek</surname><given-names>TG</given-names></name><name><surname>Suhandiman</surname><given-names>T</given-names></name></person-group><article-title>Zika virus, a cause of fever in Central Java, Indonesia</article-title><source>Trans R Soc Trop Med Hyg.</source><year>1981</year><volume>75</volume><fpage>389</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1016/0035-9203(81)90100-0</pub-id><?supplied-pmid 6275577?><pub-id pub-id-type="pmid">6275577</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kindhauser</surname><given-names>MK</given-names></name><name><surname>Allen</surname><given-names>T</given-names></name><name><surname>Frank</surname><given-names>V</given-names></name><name><surname>Santhana</surname><given-names>RS</given-names></name><name><surname>Dye</surname><given-names>C</given-names></name></person-group><article-title>Zika: the origin and spread of a mosquito-borne virus</article-title><source>Bull World Health Organ</source><year>2016</year><volume>94</volume><fpage>675</fpage><lpage>686</lpage><pub-id pub-id-type="doi">10.2471/BLT.16.171082</pub-id><?supplied-pmid 27708473?><pub-id pub-id-type="pmid">27708473</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gourinat</surname><given-names>CA</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>O</given-names></name><name><surname>Calvez</surname><given-names>E</given-names></name><name><surname>Goarant</surname><given-names>C</given-names></name><name><surname>Dupont-Rouzeyrol</surname><given-names>M</given-names></name></person-group><article-title>Detection of Zika Virus in Urine</article-title><source>Emerg Infect Dis</source><year>2015</year><volume>21</volume><fpage>84</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.3201/eid2101.140894</pub-id><?supplied-pmid 25530324?><pub-id pub-id-type="pmid">25530324</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="other">World Health Organization (2016) Zika virus: Fact sheet <ext-link ext-link-type="uri" xlink:href="http://www.who.int/mediacentre/factsheets/zika/en/">http://www.who.int/mediacentre/factsheets/zika/en/</ext-link>. Accessed 3 Feb 2016.</mixed-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>SS</given-names></name><name><surname>Poon</surname><given-names>RW</given-names></name><name><surname>Wong</surname><given-names>SC</given-names></name></person-group><article-title>Zika virus infection-the next wave after dengue?</article-title><source>J Formos Med Assoc</source><year>2016</year><volume>115</volume><fpage>226</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1016/j.jfma.2016.02.002</pub-id><?supplied-pmid 26965962?><pub-id pub-id-type="pmid">26965962</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="other">International committee on taxonomy of viruses. <ext-link ext-link-type="uri" xlink:href="http://www.ictvonline.org/virusTaxonomy.asp">http://www.ictvonline.org/virusTaxonomy.asp</ext-link>.</mixed-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuno</surname><given-names>G</given-names></name><name><surname>Chang</surname><given-names>GJ</given-names></name><name><surname>Tsuchiya</surname><given-names>KR</given-names></name><name><surname>Karabatsos</surname><given-names>N</given-names></name><name><surname>Cropp</surname><given-names>CB</given-names></name></person-group><article-title>Phylogeny of the genus flavivirus</article-title><source>J Virol</source><year>1998</year><volume>72</volume><fpage>73</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1128/JVI.72.1.73-83.1998</pub-id><?supplied-pmid 9420202?><pub-id pub-id-type="pmid">9420202</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindenbach</surname><given-names>BD</given-names></name><name><surname>Rice</surname><given-names>CM</given-names></name></person-group><article-title>Molecular biology of flaviviruses</article-title><source>Adv Virus Res</source><year>2003</year><volume>59</volume><fpage>23</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/S0065-3527(03)59002-9</pub-id><?supplied-pmid 14696326?><pub-id pub-id-type="pmid">14696326</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="other">Purdue University. Zika virus structure revealed a critical advance in the development of treatments. Science Daily. <ext-link ext-link-type="uri" xlink:href="http://www.sciencedaily.com/releases/2016/03/160331153938.htm">www.sciencedaily.com/releases/2016/03/160331153938.htm</ext-link>. Accessed 8 June 2016.</mixed-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saxena</surname><given-names>SK</given-names></name><name><surname>Elahi</surname><given-names>A</given-names></name><name><surname>Gadugu</surname><given-names>S</given-names></name><name><surname>Prasad</surname><given-names>AK</given-names></name></person-group><article-title>Zika virus outbreak: an overview of the experimental therapeutics and treatment</article-title><source>VirusDisease.</source><year>2016</year><volume>27</volume><fpage>111</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1007/s13337-016-0307-y</pub-id><?supplied-pmid 27366760?><pub-id pub-id-type="pmid">27366760</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontes</surname><given-names>MB</given-names></name></person-group><article-title>Zika virus-related hypertensive iridocyclitis</article-title><source>Arq Bras Oftalmol.</source><year>2016</year><volume>79</volume><fpage>63</fpage><pub-id pub-id-type="doi">10.5935/0004-2749.20160020</pub-id><?supplied-pmid 26840174?><pub-id pub-id-type="pmid">26840174</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musso</surname><given-names>D</given-names></name><name><surname>Nhan</surname><given-names>TX</given-names></name></person-group><article-title>Emergence of Zika Virus</article-title><source>Clin Microbiol.</source><year>2015</year><volume>4</volume><fpage>1000222</fpage></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musso</surname><given-names>D</given-names></name><name><surname>Gubler</surname><given-names>DJ</given-names></name></person-group><article-title>Zika Virus</article-title><source>Clin Microbiol Rev</source><year>2016</year><volume>29</volume><fpage>487</fpage><lpage>524</lpage><pub-id pub-id-type="doi">10.1128/CMR.00072-15</pub-id><?supplied-pmid 4861986?><pub-id pub-id-type="pmid">27029595</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="other">World Health Organization. Countries and territories with current or previous Zika virustransmission. Updated July 2019. <ext-link ext-link-type="uri" xlink:href="https://www.who.int/emergencies/diseases/zika/countries-with-zika-and-vectors-table.pdf">https://www.who.int/emergencies/diseases/zika/countries-with-zika-and-vectors-table.pdf</ext-link>.</mixed-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duffy</surname><given-names>MR</given-names></name><name><surname>Chen</surname><given-names>T-H</given-names></name><name><surname>Hancock</surname><given-names>TW</given-names></name><name><surname>Powers</surname><given-names>AM</given-names></name><name><surname>Kool</surname><given-names>JL</given-names></name><name><surname>Lanciotti</surname><given-names>RS</given-names></name><etal/></person-group><article-title>Zika virus outbreak on Yap Island, Federated States of Micronesia</article-title><source>N Engl J Med</source><year>2009</year><volume>360</volume><fpage>2536</fpage><lpage>2543</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa0805715</pub-id><?supplied-pmid 19516034?><pub-id pub-id-type="pmid">19516034</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horwood</surname><given-names>P</given-names></name><name><surname>Bande</surname><given-names>G</given-names></name><name><surname>Dagina</surname><given-names>R</given-names></name><name><surname>Guillaumot</surname><given-names>L</given-names></name><name><surname>Aaskov</surname><given-names>J</given-names></name><name><surname>Pavlin</surname><given-names>B</given-names></name></person-group><article-title>The threat of chikungunya in Oceania</article-title><source>Western Pac Surveill Response J.</source><year>2013</year><volume>4</volume><fpage>8</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.5365/wpsar.2013.4.2.003</pub-id><?supplied-pmid 3762969?><pub-id pub-id-type="pmid">24015365</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musso</surname><given-names>D</given-names></name><name><surname>Nilles</surname><given-names>EJ</given-names></name><name><surname>Cao-Lormeau</surname><given-names>VM</given-names></name></person-group><article-title>Rapid spread of emerging Zika virus in the Pacific area</article-title><source>Clin Microbiol Infect</source><year>2014</year><volume>20</volume><fpage>O595</fpage><lpage>O596</lpage><pub-id pub-id-type="doi">10.1111/1469-0691.12707</pub-id><?supplied-pmid 24909208?><pub-id pub-id-type="pmid">24909208</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lourenco-de-Oliveira</surname><given-names>R</given-names></name><name><surname>Rua</surname><given-names>AV</given-names></name><name><surname>Vezzani</surname><given-names>D</given-names></name><name><surname>Willat</surname><given-names>G</given-names></name><name><surname>Vazeille</surname><given-names>M</given-names></name><name><surname>Mousson</surname><given-names>L</given-names></name><etal/></person-group><article-title><italic>Aedes aegypti</italic> from temperate regions of South America are highly competent to transmit dengue virus</article-title><source>BMC Infect Dis</source><year>2013</year><volume>13</volume><fpage>610</fpage><pub-id pub-id-type="doi">10.1186/1471-2334-13-610</pub-id><?supplied-pmid 24373423?><pub-id pub-id-type="pmid">24373423</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chouin-Carneiro</surname><given-names>T</given-names></name><name><surname>Vega-Rua</surname><given-names>A</given-names></name><name><surname>Vazeille</surname><given-names>M</given-names></name><name><surname>Yebakima</surname><given-names>A</given-names></name><name><surname>Girod</surname><given-names>R</given-names></name><name><surname>Goindin</surname><given-names>D</given-names></name><etal/></person-group><article-title>Differential susceptibilities of <italic>Aedes aegypti</italic> and <italic>Aedes albopictus</italic> from the Americas to Zika Virus</article-title><source>PLoS Negl Trop Dis.</source><year>2016</year><volume>10</volume><fpage>e0004543</fpage><pub-id pub-id-type="doi">10.1371/journal.pntd.0004543</pub-id><?supplied-pmid 26938868?><pub-id pub-id-type="pmid">26938868</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>EB</given-names></name></person-group><article-title>Zika virus outside Africa</article-title><source>Emerg Infect Dis</source><year>2009</year><volume>15</volume><fpage>1347</fpage><lpage>1350</lpage><pub-id pub-id-type="doi">10.3201/eid1509.090442</pub-id><?supplied-pmid 19788800?><pub-id pub-id-type="pmid">19788800</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berthet</surname><given-names>N</given-names></name><name><surname>Nakoun&#x000e9;</surname><given-names>E</given-names></name><name><surname>Kamgang</surname><given-names>B</given-names></name><name><surname>Selekon</surname><given-names>B</given-names></name><name><surname>Descorps-Decl&#x000e8;re</surname><given-names>S</given-names></name><name><surname>Gessain</surname><given-names>A</given-names></name><etal/></person-group><article-title>Molecular characterization of three Zika flaviviruses obtained from sylvatic mosquitoes in the Central African Republic</article-title><source>Vector Borne Zoonotic Dis.</source><year>2014</year><volume>14</volume><fpage>862</fpage><lpage>865</lpage><pub-id pub-id-type="doi">10.1089/vbz.2014.1607</pub-id><?supplied-pmid 25514122?><pub-id pub-id-type="pmid">25514122</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guedes</surname><given-names>DR</given-names></name><name><surname>Paiva</surname><given-names>MH</given-names></name><name><surname>Donato</surname><given-names>MM</given-names></name><name><surname>Barbosa</surname><given-names>PP</given-names></name><name><surname>Krokovsky</surname><given-names>L</given-names></name><name><surname>Rocha</surname><given-names>SWDS</given-names></name><etal/></person-group><article-title>Zika virus replication in the mosquito <italic>Culex quinquefasciatus</italic> in Brazil</article-title><source>Emerg Microbes Infect.</source><year>2017</year><volume>6</volume><fpage>e69</fpage><pub-id pub-id-type="doi">10.1038/emi.2017.59</pub-id><?supplied-pmid 28790458?><pub-id pub-id-type="pmid">28790458</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Besnard</surname><given-names>M</given-names></name><name><surname>Last&#x000e8;re</surname><given-names>S</given-names></name><name><surname>Teissier</surname><given-names>A</given-names></name><name><surname>Cao-Lormeau</surname><given-names>V</given-names></name><name><surname>Musso</surname><given-names>D</given-names></name></person-group><article-title>Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014</article-title><source>Euro Surveill</source><year>2014</year><volume>19</volume><fpage>20751</fpage><pub-id pub-id-type="doi">10.2807/1560-7917.ES2014.19.13.20751</pub-id><?supplied-pmid 24721538?><pub-id pub-id-type="pmid">24721538</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="other">ProMED-mail. 23 December 2015. Zika virus&#x02014;Americas, Atlantic Ocean. ProMED-mail archive no. 20151223.3886435. <ext-link ext-link-type="uri" xlink:href="http://www.promedmail.org">http://www.promedmail.org</ext-link>. Accessed 1 Feb 2016.</mixed-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fagbami</surname><given-names>AH</given-names></name></person-group><article-title>Zika virus infections in Nigeria: virological and seroepidemiological investigations in Oyo State</article-title><source>J Hyg</source><year>1979</year><volume>83</volume><fpage>213</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1017/S0022172400025997</pub-id><?supplied-pmid 489960?><pub-id pub-id-type="pmid">489960</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="other">LaBeaud AD. 2016. ZIKV infection: an overview. <ext-link ext-link-type="uri" xlink:href="http://www.uptodate.com/contents/zika-virus-infection-an-overview">http://www.uptodate.com/contents/zika-virus-infection-an-overview</ext-link>.</mixed-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ioos</surname><given-names>S</given-names></name><name><surname>Mallet</surname><given-names>HP</given-names></name><name><surname>Leparc Goffart</surname><given-names>I</given-names></name><name><surname>Gauthier</surname><given-names>V</given-names></name><name><surname>Cardoso</surname><given-names>T</given-names></name><name><surname>Herida</surname><given-names>M</given-names></name></person-group><article-title>Current Zika virus epidemiology and recent epidemics</article-title><source>Med Mal Infect.</source><year>2014</year><volume>44</volume><fpage>302</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1016/j.medmal.2014.04.008</pub-id><?supplied-pmid 25001879?><pub-id pub-id-type="pmid">25001879</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><mixed-citation publication-type="other">Rapid risk assessment: Zika virus epidemic in the Americas: potential association with microcephaly and Guillain&#x02013;Barr&#x000e9; syndrome. Stockholm: European Centre for Disease Prevention and Control, December 10, 2015 (<ext-link ext-link-type="uri" xlink:href="http://ecdceuropa.eu/en/publications/Publications/zika-virus-americas-association-with-microcephaly-rapid-risk-assessment.pdf">http://ecdceuropa.eu/en/publications/Publications/zika-virus-americas-association-with-microcephaly-rapid-risk-assessment.pdf</ext-link>).</mixed-citation></ref><ref id="CR52"><label>52.</label><mixed-citation publication-type="other">Australian government department of health, ZIKV&#x02014;information for clinicians and public health practitioners. <ext-link ext-link-type="uri" xlink:href="http://www.health.gov.au/internet/main/publishing.nsf/Content/ohp-zika-health-practitioners.htm#toc01">http://www.health.gov.au/internet/main/publishing.nsf/Content/ohp-zika-health-practitioners.htm#toc01</ext-link>.</mixed-citation></ref><ref id="CR53"><label>53.</label><mixed-citation publication-type="other">Pan American Health Organization (PAHO). 2016. Epidemiological Update Neurological syndrome, congenital anomalies, and Zika virus infection. <ext-link ext-link-type="uri" xlink:href="http://www.paho.org/hq/index.php%3foption%3dcom_docman%26task%3ddoc_view%26Itemid%3d270%26gid%3d32879%26lang%3den">http://www.paho.org/hq/index.php?option=com_docman&#x00026;task=doc_view&#x00026;Itemid=270&#x00026;gid=32879&#x00026;lang=en</ext-link>.</mixed-citation></ref><ref id="CR54"><label>54.</label><mixed-citation publication-type="other">European Centre for Disease Prevention and Control. Rapid risk assessment: ZIKV infection outbreak, Brazil and the Pacific region. 25 May 2015. <ext-link ext-link-type="uri" xlink:href="http://ecdc.europa.eu/en/publications/Publications/rapidrisk-assessment-Zika%20virus-south-america-Brazil-2015.pdf">http://ecdc.europa.eu/en/publications/Publications/rapidrisk-assessment-Zika%20virus-south-america-Brazil-2015.pdf</ext-link>.</mixed-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pithadia</surname><given-names>AB</given-names></name><name><surname>Kakadia</surname><given-names>N</given-names></name></person-group><article-title>Guillain&#x02013;Barr&#x000e9; syndrome (GBS)</article-title><source>Pharmacol Rep.</source><year>2010</year><volume>62</volume><fpage>220</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1016/S1734-1140(10)70261-9</pub-id><?supplied-pmid 20508277?><pub-id pub-id-type="pmid">20508277</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao-Lormeau</surname><given-names>VM</given-names></name><name><surname>Blake</surname><given-names>A</given-names></name><name><surname>Mons</surname><given-names>S</given-names></name><name><surname>Last&#x000e8;re</surname><given-names>S</given-names></name><name><surname>Roche</surname><given-names>C</given-names></name><name><surname>Vanhomwegen</surname><given-names>J</given-names></name><etal/></person-group><article-title>Guillain&#x02013;Barr&#x000e9; syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study</article-title><source>Lancet</source><year>2016</year><volume>387</volume><fpage>1531</fpage><lpage>1539</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(16)00562-6</pub-id><?supplied-pmid 26948433?><pub-id pub-id-type="pmid">26948433</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malkki</surname><given-names>H</given-names></name></person-group><article-title>Zika virus infection could trigger Guillain&#x02013;Barr&#x000e9; syndrome</article-title><source>Nat Rev Neurol.</source><year>2016</year><pub-id pub-id-type="doi">10.1038/nrneurol.2016.30</pub-id><?supplied-pmid 27982042?><pub-id pub-id-type="pmid">27982042</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bandyopadhyay</surname><given-names>B</given-names></name><name><surname>Das</surname><given-names>S</given-names></name><name><surname>Sengupta</surname><given-names>M</given-names></name><name><surname>Saha</surname><given-names>C</given-names></name><name><surname>Das</surname><given-names>KC</given-names></name><name><surname>Sarkar</surname><given-names>D</given-names></name><etal/></person-group><article-title>Decreased intensity of Japanese encephalitis virus infection in chick chorioallantoic membrane under influence of ultradiluted Belladonna extract</article-title><source>Am J Infect Dis.</source><year>2010</year><volume>6</volume><fpage>24</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.3844/ajidsp.2010.24.28</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowson</surname><given-names>JM</given-names></name></person-group><article-title>The pharmacognosy <italic>of Atropa belladonna</italic> LINN</article-title><source>J Pharm Pharmacol</source><year>1950</year><pub-id pub-id-type="doi">10.1111/j.2042-7158.1950.tb12925.x</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajput</surname><given-names>H</given-names></name></person-group><article-title>Effects of <italic>Atropa belladonna</italic> as anti-cholinergic</article-title><source>Nat Prod Chem Res.</source><year>2013</year><volume>1</volume><fpage>104</fpage></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rita</surname><given-names>P</given-names></name><name><surname>Animesh</surname><given-names>DK</given-names></name></person-group><article-title>An updated overview on <italic>Atropa belladonna</italic> L.</article-title><source>Int Res J Pharm.</source><year>2011</year><volume>2</volume><fpage>11</fpage><lpage>17</lpage></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulbricht</surname><given-names>C</given-names></name><name><surname>Basch</surname><given-names>E</given-names></name><name><surname>Hammerness</surname><given-names>P</given-names></name><name><surname>Vora</surname><given-names>M</given-names></name><name><surname>Wylie</surname><given-names>J</given-names></name><name><surname>Woods</surname><given-names>J</given-names></name></person-group><article-title>An evidence-based systematic review of Belladonna by the Natural Standard Research Collaboration</article-title><source>J Herb Pharmacother.</source><year>2004</year><volume>4</volume><fpage>61</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1080/J157v04n04_06</pub-id><?supplied-pmid 15927926?><pub-id pub-id-type="pmid">15927926</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calvet</surname><given-names>G</given-names></name><name><surname>Aguiar</surname><given-names>RS</given-names></name><name><surname>Melo</surname><given-names>ASO</given-names></name><name><surname>Sampaio</surname><given-names>SA</given-names></name><name><surname>de Filippis</surname><given-names>I</given-names></name><name><surname>Fabri</surname><given-names>A</given-names></name><etal/></person-group><article-title>Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study</article-title><source>Lancet Infect Dis.</source><year>2016</year><volume>16</volume><fpage>653</fpage><lpage>660</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(16)00095-5</pub-id><?supplied-pmid 26897108?><pub-id pub-id-type="pmid">26897108</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bousta</surname><given-names>D</given-names></name><name><surname>Soulimani</surname><given-names>R</given-names></name><name><surname>Jarmouni</surname><given-names>I</given-names></name><name><surname>Belon</surname><given-names>P</given-names></name><name><surname>Falla</surname><given-names>J</given-names></name><name><surname>Froment</surname><given-names>N</given-names></name><etal/></person-group><article-title>Neurotropic, immunological and gastric effects of low doses of <italic>Atropa belladonna</italic> L., <italic>Gelsemium sempervirens</italic> L. and Poumon histamine in stressed mice</article-title><source>J Ethnopharmacol</source><year>2001</year><volume>74</volume><fpage>205</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(00)00346-9</pub-id><?supplied-pmid 11274819?><pub-id pub-id-type="pmid">11274819</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ullman</surname><given-names>D</given-names></name></person-group><article-title>Controlled clinical trials evaluating the homeopathic treatment of people with human immunodeficiency virus or acquired immune deficiency syndrome</article-title><source>J Altern Complement Med</source><year>2003</year><volume>9</volume><fpage>133</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1089/107555303321223008</pub-id><?supplied-pmid 12676041?><pub-id pub-id-type="pmid">12676041</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patwardhan</surname><given-names>B</given-names></name><name><surname>Vaidya</surname><given-names>ADB</given-names></name><name><surname>Chorghade</surname><given-names>M</given-names></name></person-group><article-title>Ayurveda and natural products drug discovery</article-title><source>Curr Sci</source><year>2004</year><volume>86</volume><fpage>789</fpage><lpage>799</lpage></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mittal</surname><given-names>J</given-names></name><name><surname>Sharma</surname><given-names>MM</given-names></name><name><surname>Batra</surname><given-names>A</given-names></name></person-group><article-title><italic>Tinospora cordifolia</italic>: a multipurpose medicinal plant&#x02014;a review</article-title><source>J Med Plants Stud.</source><year>2014</year><volume>2</volume><fpage>32</fpage><lpage>47</lpage></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackman</surname><given-names>JA</given-names></name><name><surname>Costa</surname><given-names>VV</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Real</surname><given-names>ALC</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Cardozo</surname><given-names>PL</given-names></name><etal/></person-group><article-title>Therapeutic treatment of Zika virus infection using a brain-penetrating antiviral peptide</article-title><source>Nature Mater.</source><year>2018</year><volume>17</volume><fpage>971</fpage><lpage>977</lpage><pub-id pub-id-type="doi">10.1038/s41563-018-0194-2</pub-id><pub-id pub-id-type="pmid">30349030</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quanquin</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Cheng</surname><given-names>G</given-names></name></person-group><article-title>Potential for treatment and a Zika virus vaccine</article-title><source>Curr Opin Pediatr</source><year>2017</year><volume>29</volume><fpage>114</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1097/MOP.0000000000000441</pub-id><?supplied-pmid 27906864?><pub-id pub-id-type="pmid">27906864</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez</surname><given-names>E</given-names></name><name><surname>Diamond</surname><given-names>MS</given-names></name></person-group><article-title>Vaccination strategies against Zika virus</article-title><source>Curr Opin Virol.</source><year>2017</year><volume>23</volume><fpage>59</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.coviro.2017.03.006</pub-id><?supplied-pmid 28432975?><pub-id pub-id-type="pmid">28432975</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbink</surname><given-names>P</given-names></name><name><surname>Stephenson</surname><given-names>KE</given-names></name><name><surname>Barouch</surname><given-names>DH</given-names></name></person-group><article-title>Zika virus vaccines</article-title><source>Nat Rev Microbiol</source><year>2018</year><volume>16</volume><fpage>594</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1038/s41579-018-0039-7</pub-id><?supplied-pmid 29921914?><pub-id pub-id-type="pmid">29921914</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekins</surname><given-names>S</given-names></name><name><surname>Mietchen</surname><given-names>D</given-names></name><name><surname>Coffee</surname><given-names>M</given-names></name><name><surname>Stratton</surname><given-names>TP</given-names></name><name><surname>Freundlich</surname><given-names>JS</given-names></name><name><surname>Freitas-Junior</surname><given-names>L</given-names></name><etal/></person-group><article-title>Open drug discovery for the Zika virus</article-title><source>F1000Res</source><year>2016</year><volume>5</volume><fpage>150</fpage><pub-id pub-id-type="doi">10.12688/f1000research.8013.1</pub-id><?supplied-pmid 27134728?><pub-id pub-id-type="pmid">27134728</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><mixed-citation publication-type="other">Pan American Health Organization. 2015. Zika virus (ZIKV) surveillance in the Americas: interim guidance for laboratory detection and diagnosis. Pan American Health Organization, Washington, DC.<ext-link ext-link-type="uri" xlink:href="http://www.paho.org/hq/index.php%3foption%3dcom_docman%26task%3ddoc_view%26gid%3d30176%26Itemid%3d270">http://www.paho.org/hq/index.php?option=com_docman&#x00026;task=doc_view&#x00026;gid=30176&#x00026;Itemid=270</ext-link>.</mixed-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Organization</surname><given-names>Pan American Health</given-names></name></person-group><source>Epidemiological alert. Neurological syndrome, congenital malformations, and Zika virus infections. Implications for public health in the Americas</source><year>2015</year><publisher-loc>Washington</publisher-loc><publisher-name>Pan American Health Organization</publisher-name></element-citation></ref><ref id="CR75"><label>75.</label><mixed-citation publication-type="other">National Center for Health Statistics, key messages&#x02014;ZIKV disease, Centre of disease control. <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/zika/pdfs/zika-key-messages.pdf">http://www.cdc.gov/zika/pdfs/zika-key-messages.pdf</ext-link>.</mixed-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burd</surname><given-names>I</given-names></name><name><surname>Griffin</surname><given-names>D</given-names></name></person-group><article-title>The chasm between public health and reproductive research: what history tells us about Zika virus</article-title><source>J Assist Reprod Genet</source><year>2016</year><volume>33</volume><fpage>439</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1007/s10815-016-0687-3</pub-id><?supplied-pmid 26943916?><pub-id pub-id-type="pmid">26943916</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benelli</surname><given-names>G</given-names></name><name><surname>Jeffries</surname><given-names>CL</given-names></name><name><surname>Walker</surname><given-names>T</given-names></name></person-group><article-title>Biological control of mosquito vectors: past, present, and future</article-title><source>Insects.</source><year>2016</year><volume>7</volume><fpage>E52</fpage><pub-id pub-id-type="doi">10.3390/insects7040052</pub-id><?supplied-pmid 27706105?><pub-id pub-id-type="pmid">27706105</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>RK</given-names></name><name><surname>Dhama</surname><given-names>K</given-names></name><name><surname>Malik</surname><given-names>YS</given-names></name><name><surname>Ramakrishnan</surname><given-names>MA</given-names></name><name><surname>Karthik</surname><given-names>K</given-names></name><name><surname>Tiwari</surname><given-names>R</given-names></name><etal/></person-group><article-title>Zika virus&#x02014;emergence, evolution, pathology, diagnosis, and control: current global scenario and future perspectives&#x02014;a comprehensive review</article-title><source>Vet Q.</source><year>2016</year><volume>36</volume><fpage>150</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1080/01652176.2016.1188333</pub-id><?supplied-pmid 27158761?><pub-id pub-id-type="pmid">27158761</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>SL</given-names></name><name><surname>Tesh</surname><given-names>RB</given-names></name><name><surname>Azar</surname><given-names>SR</given-names></name><name><surname>Muruato</surname><given-names>AE</given-names></name><name><surname>Hanley</surname><given-names>KA</given-names></name><name><surname>Auguste</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Characterization of a novel murine model to study Zika virus</article-title><source>Am J Trop Med Hyg</source><year>2016</year><volume>94</volume><fpage>1362</fpage><lpage>1369</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.16-0111</pub-id><?supplied-pmid 27022155?><pub-id pub-id-type="pmid">27022155</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGrath</surname><given-names>EL</given-names></name><name><surname>Rossi</surname><given-names>SL</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Widen</surname><given-names>SG</given-names></name><name><surname>Grant</surname><given-names>AC</given-names></name><name><surname>Dunn</surname><given-names>TJ</given-names></name><etal/></person-group><article-title>Differential responses of human fetal brain neural stem cells to Zika virus infection</article-title><source>Stem Cell Reports.</source><year>2017</year><volume>8</volume><fpage>715</fpage><lpage>727</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2017.01.008</pub-id><?supplied-pmid 28216147?><pub-id pub-id-type="pmid">28216147</pub-id></element-citation></ref></ref-list></back></article>